Bostal Drug Delivery Co., Ltd
3 clinical trials · Sponsor
◉ Watch Bostal Drug Delivery Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With Schizophrenia (NCT07722728) | Bostal Drug Delivery Co., Ltd | 2026-08-01 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection in Subjects With Schizophrenia (NCT07742280) | Bostal Drug Delivery Co., Ltd | 2026-08-01 |
| A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects (NCT06422624) | Bostal Drug Delivery Co., Ltd | 2024-08-01 |
Track Bostal Drug Delivery Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.